Insmed Inc
(NAS:INSM)
$
69.19
1.1 (1.62%)
Market Cap: 12.38 Bil
Enterprise Value: 11.78 Bil
PE Ratio: 0
PB Ratio: 25.63
GF Score: 63/100 Insmed Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2022 / 01:55PM GMT
Release Date Price:
$25.28
(+1.81%)
Jeff Hung
Morgan Stanley, Research Division - Equity Analyst
Good morning. Welcome to the Morgan Stanley Global Healthcare Conference. I'm Jeff Hung, one of the biotech analysts. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. For this session, we have Insmed with CEO, Will Lewis. Welcome, Will.
William H. Lewis
Insmed Incorporated - President, CEO & Chairman
Thank you.
Questions & Answers
Jeff Hung
Morgan Stanley, Research Division - Equity Analyst
For those who may not be familiar with Insmed, can you provide a brief introduction?
William H. Lewis
Insmed Incorporated - President, CEO & Chairman
Sure. So we think of Insmed as organized around 4 pillars. The first pillar is ARIKAYCE, this is
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot